Navigation Links
GlySure Secures $10.9 Million in Series C Financing Round
Date:1/9/2012

OXFORD, England, January 9, 2012 /PRNewswire/ --

GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, today announced the close of its $10.9 million Series C financing round. GlySure will use this funding to complete clinical trials to supportregulatory approval in the United States and Europe.

The financing round was supported by Morningside Venture, as well as existing investors Amadeus Capital Partners, Chester Investments and Delta Partners. Since its foundation in May 2006, GlySure has secured a total of $19.5 million in venture capital funding.

"We are excited about the opportunity to support GlySure's regulatory trials," said Reenie McCarthy, representing Morningside Venture. "There is a significant unmet need for continuous glucose monitoring in critical care, and the results from GlySure's initial ICU trials show that the company is on track to deliver the performance and ease-of-use required to enable clinicians to effectively implement Tight Glycemic Control."

GlySure recently completed initialhuman use trials on over 90 intensive care patients. The trials demonstrated that the GlySure system can accurately measure blood glucose levels across the entire human physiological range for the duration of a patient's stay in the Intensive Care Unit(ICU).

"This new financing round recognizes not only the significant clinical results, but also the management team's capital efficiency and ability to cost effectively deliver a product with the potential to improve outcomes for over 8 million ICU patients annually," added Dr. Joey Mason, partner at Delta Partners and a director of GlySure.

"There have been over 100 publications demonstrating the ability of Tight Glycemic Control to improve outcomes and reduce cost in the ICU," said Chris Jones, GlySure CEO. "We are grateful for the support of our existing and new investors and look forward to completing our regulatory trials so that we can
'/>"/>

SOURCE GlySure
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
3. GeoVax Secures $10 Million Financing Commitment
4. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
5. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
6. ALung Secures $2.5 Million
7. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
8. EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital
9. HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing
10. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
11. TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013 ... promoted through new ,Wake-Up Call, campaign and ICD-10 ... a world-leading provider of scientific, technical and medical ... of EduCode ® Doc Briefs , ... other practitioners. EduCode Doc Briefs is available on ...
(Date:6/17/2013)... June 17, 2013  The American Society of ... report on the effectiveness of medications for opioid ... FDA-approved drugs by many state governments and insurance ... drunk driving car crashes, an epidemic led by ... heroin. Yet, safe and effective medications to treat ...
(Date:6/17/2013)... -- The law firm of Rheingold, Valet, Rheingold, McCartney & ... the first suit in New York ... two common anti-diabetic drugs, Byetta and Janumet (also known as ... resident Robert Cataletto , was filed on June 14, ... 13-3411. Mr. Cataletto received prescriptions from the doctor ...
Breaking Medicine Technology:Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 2Elsevier Launches EduCode Doc Briefs to Help Physicians Implement ICD-10 3Effective Rx thwarted for deadly opiate epidemic 2Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
(Date:6/17/2013)... 2013 The Woodstock Fruit Festival is proud ... Festival this summer, which will be held in Diamond Point, ... , Blake professes the benefits he's received by regularly ... fuel his world class sprinting abilities. Fruit is commonly considered ... drawing attention. "Yohan Blake believes in the power of natural ...
(Date:6/17/2013)... 2013 MelanSol® All Natural Skin Care ... the US distributor for MelanSol®, has partnered with the ... Food Bank to support their efforts to feed ... that they receive a portion of every sale of ... Moisturizer. Contributions will be given on sales from ...
(Date:6/17/2013)... A team from the New York Stem Cell ... Center of Columbia University has generated patient-specific beta cells, ... maturity-onset diabetes of the young (MODY). , The ... induced pluripotent stem (iPS) cells, from which they then ... cell-derived beta cells secreted insulin in a manner similar ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a ... has recently undergone a mainstream culture explosion. Interpretation of the ... Surgery, they regard the term to mean a combination of ... of the effects of pregnancy on a woman’s body. ... the breast with gain or loss of volume, widening of ...
(Date:6/17/2013)... pyrvinium pamoate inhibits aggressive forms of prostate cancer that ... conducted in an animal model. The results will be ... in San Francisco. , "Our novel prostate cancer drug ... lead author Jeremy Jones, PhD, assistant professor of molecular ... Duarte, CA. "Thus, it has the potential to treat ...
Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2
... has passed a resolution that from now on all ... the pathogen, Enterobacter sakazakii. ,These strong warning ... label proclaiming mother’s milk as the best for infants. ... reported by consumption of contaminated baby formula. A French ...
... H5N1 has mutated since 2002 to become more dangerous ... ,The Asian strain H5N1 influenza virus has changed its ... to ducks; the virus multiplies in the ducks without infecting ... duck Waterfowl is a natural host for H5N1 influenza virus, ...
... be responsible for birth defects, cancer and other health ... used genetically modified mice to see how the microRNAs ... the mice were grown without the microRNA molecules they ... ,MicroRNA (miRNA) are small RNA molecules that control the ...
... new study presented at the Annual Congress for Dermatological Research ... marketed by Paris-based IsoCell Nutra, significantly increased the levels of ... that SOD has a different mode of action to vitamins. ... discovered in 1968, it is the first antioxidant mobilized by ...
... noticed in women consuming a diet rich in calcium and ... at the University of Massachusetts at Amherst conducted the study. ... who participated in the Nurse Health Study II and developed ... not develop PMS. This data was analysed and interpreted., ...
... two months of previous prescription of antibiotics increases //the ... than in people who were given antibiotics after almost ... levels of taking antibiotics are harmful to health as ... is the first study that assesses the risk to ...
Cached Medicine News:Health News:Influenza Avian Flu strain has become more contagious and dangerous. , 2Health News:Influenza Avian Flu strain has become more contagious and dangerous. , 3Health News:New Supplement Found To Be Effective Against Sunburn 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: